We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · February 24, 2021

Ultra-Hypofractionated Proton Radiotherapy for Low- and Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics


Additional Info

International Journal of Radiation Oncology, Biology, Physics
Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer: 5-Year Outcomes.
Int. J. Radiat. Oncol. Biol. Phys 2021 Feb 12;[EPub Ahead of Print], J Kubeš, A Haas, V Vondráček, M Andrlík, M Navrátil, S Sláviková, P Vítek, K Dědečková, J Prausová, B Ondrová, Š Vinakurau, A Grebenyuk, T Doležal, B Velacková, J Rosina

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading